Table: Taiko Pharmaceutical -6-MTH group results

Taiko Pharmaceutical

11/11/2016 06:00

Nov 11 (Reuters)-  
             Taiko Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               2.98                3.24             8.40      
                   (-8.0 pct)          (-11.3 pct)      (+0.9 pct)   
  Operating          474 mln             397 mln           1.35      
                   (+19.2 pct)         (-59.0 pct)      (+0.2 pct)   
  Recurring          318 mln             405 mln           1.11      
                   (-21.3 pct)         (-62.5 pct)      (-15.1 pct)  
  Net                254 mln             123 mln          850 mln    
                  (+106.2 pct)         (-82.4 pct)      (+1.2 pct)   
  EPS               18.91 yen           9.63 yen         65.24 yen   
  EPS Diluted       18.73 yen           9.38 yen                     
  Ann Div                               15.00 yen        15.00 yen   
  -Q2 div              NIL                 NIL                       
  -Q4 div                               15.00 yen        15.00 yen   
   
  NOTE - Taiko Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T  
  ((Tokyo Headline News Desk +813 6441 1812))